Zoledronate modulates intracellular vesicle trafficking in mast cells via disturbing the interaction of myosinVa/Rab3a and sytaxin4/VAMP7. [electronic resource]
Producer: 20190109Description: 18-25 p. digitalISSN:- 1873-2968
- Animals
- Bone Density Conservation Agents -- pharmacology
- Cell Line, Tumor
- Exocytosis -- drug effects
- Histamine Release -- drug effects
- Mast Cells -- drug effects
- Myosin Heavy Chains -- metabolism
- Myosin Type V -- metabolism
- Protein Binding
- Qa-SNARE Proteins -- metabolism
- R-SNARE Proteins -- metabolism
- Rats
- Transport Vesicles -- drug effects
- Zoledronic Acid -- pharmacology
- rab3A GTP-Binding Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.